The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries

PURPOSE: To describe the frequency and variation of intravitreal bevacizumab and ranibizumab use for branch retinal vein occlusion (BVO) in the United States (US). METHODS: We obtained a 5% random sample of Medicare beneficiaries from the Medicare Denominator and Physician/Supplier Part B claims fil...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Annie M., Wu, Connie M., Greenberg, Paul B., Yu, Fei, Lum, Flora, Coleman, Anne L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Brief report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038825/
https://www.ncbi.nlm.nih.gov/pubmed/29998209
http://dx.doi.org/10.1016/j.ajoc.2018.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038825/
https://www.ncbi.nlm.nih.gov/pubmed/29998209
http://dx.doi.org/10.1016/j.ajoc.2018.06.005

Ejemplares similares